Evaluating the Role of α-Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties.

Mov Disord Clin Pract · 2026 · PMC13172763 · PMID 41235570

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

TTT ( p = 0.07) and Tsmax ( P = 0.09) from the Amprion‐24 h αS‐SAA version showed a trend to improve model fit for RBDSQ question‐6.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.